Biocodex/Florastor

Biocodex Corporate Description Short  

 

Since 1953, Biocodex teams have been passionately committed to a single mission: providing innovative healthcare solutions to women, men and children worldwide. With over 1,600 employees, Biocodex is committed to serving millions of people around the world.  

 
Biocodex USA markets Florastor® daily probiotic, (Saccharomyces boulardii CNCM I-745®) that supports digestive balance and strengthens the immune system. Florastor is the only probiotic in North America to contain the original and exclusive yeast strain, S. boulardii CNCM I-745, supported by over 70 years of research, over 1,000 publications, more than 130 clinical studies and over 13 meta-analyses. Unlike most bacteria-based probiotics, Florastor is naturally resistant to antibiotics and therefore can be taken at the same time to enhance patient compliance.